首页 › 基金 › Harpswell Capital Advisors, LLC › RCEL

Harpswell Capital Advisors, LLC 对 RCEL 的持仓历史

AVITA MEDICAL INC · 医疗保健

Harpswell Capital Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 RCEL(AVITA MEDICAL INC)12,822 股,市值约 US$150K,约占其申报组合的 0.10%,在其申报持仓中市值排名第 42 位。 Harpswell Capital Advisors, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)12.82K 股
申报持仓市值$150.40K
组合权重0.10%
首次申报Q3 2026
最近变动新进
更新于2026-10-09

最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR

Harpswell Capital Advisors, LLC 对 RCEL 的持仓演变

Harpswell Capital Advisors, LLC 于 Q3 2026 首次披露 RCEL 持仓:12,822 股(约 US$150K)。

逐季持仓明细

季度股数金额变化
Q3 2026 12.82K $150.40K 新进

关于 RCEL 与 13F 数据

RCEL(AVITA MEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 RCEL。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RCEL 的基金

暂无其它被追踪基金申报持有 RCEL.

查看 RCEL 的全部基金持有人 →

常见问题

How long has Harpswell Capital Advisors, LLC held RCEL?

Harpswell Capital Advisors, LLC has disclosed RCEL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Harpswell Capital Advisors, LLC's current position in RCEL?

As of Q3 2026, Harpswell Capital Advisors, LLC holds 12.82K shares of RCEL (AVITA MEDICAL INC), valued at $150.40K, representing 0.10% of its reported portfolio and ranking #42.

Has Harpswell Capital Advisors, LLC been buying or selling RCEL?

In the latest 13F filing (Q3 2026), Harpswell Capital Advisors, LLC newly opened its position in RCEL.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.